Journal Article

Homozygous IL37 mutation associated with infantile inflammatory bowel disease

Ertem, Deniz, Yao, Yikun, Zhang, Yu, Barisc, Safa, Su, Helen C., Ozen, Ahmet, He, Tingyan, Sweeney, Colin L., Malech, Harry L., Karakoc-Aydiner, Elif, Matthews, Helen F., Smith, Kenneth G. C., Zhang, Zinan Z., Gonzaga-Jauregui, Claudia, Lenardo, Michael J.

2021

Overview

Interleukin (IL)-37, an antiinflammatory IL-1 family cytokine, is a key suppressor of innate immunity. IL-37 signaling requires the heterodimeric IL-18R1 and IL-1R8 receptor, which is abundantly expressed in the gastrointestinal tract. Here we report a 4-mo-old male from a consanguineous family with a homozygous loss-offunction IL37 mutation. The patient presented with persistent diarrhea and was found to have infantile inflammatory bowel disease (I-IBD). Patient cells showed increased intracellular IL-37 expression and increased proinflammatory cytokine production. In cell lines, mutant IL-37 was not stably expressed or properly secreted and was thus unable to functionally suppress proinflammatory cytokine expression. Furthermore, induced pluripotent stem cell–derived macrophages from the patient revealed an activated macrophage phenotype, which is more prone to lipopolysaccharide and IL-1β stimulation, resulting in hyperinflammatory tumor necrosis factor production. Insights from this patient will not only shed light on monogenic contributions of I-IBD but may also reveal the significance of the IL-18 and IL-37 axis in colonic homeostasis.

• Publisher: National Academy of Sciences
• Subject: Biological Sciences / BRIEF REPORT / Cytokines / Diarrhea / Gastrointestinal system / Gastrointestinal tract / Homeostasis / IL-1β / Immunology and Inflammation / Inflammatory bowel disease / Inflammatory bowel diseases / Innate immunity / Interleukin 1 / Interleukin 1 receptors / Interleukin 18 / Intestine / Lipopolysaccharides / Macrophages / Mutation / Phenotypes / Pluripotency / Stem cells